López-Sanromán A - Search Results

1

What is the real-life maintenance mesalazine dose in ulcerative colitis?

Algaba A, Guerra I, García García de Paredes A, Hernández Tejero M, Ferre C, Bonillo D, Aguilera L, López-Sanromán A, Bermejo F. Algaba A, et al. Rev Esp Enferm Dig. 2017 Feb;109(2):114-121. doi: 10.17235/reed.2016.4620/2016. Rev Esp Enferm Dig. 2017. PMID: 28026200 Free article.

2

Pyoderma gangrenosum associated with ulcerative colitis: response to infliximab.

López San Román A, Bermejo F, Aldanondo I, Carrera E, Boixeda D, Muñoz Zato E. López San Román A, et al. Rev Esp Enferm Dig. 2004 Jun;96(6):420-2; 422-4. doi: 10.4321/s1130-01082004000600008. Rev Esp Enferm Dig. 2004. PMID: 15230672 English, Spanish.

3

Infliximab induces clinical, endoscopic and histological responses in refractory ulcerative colitis.

Bermejo F, López-Sanroman A, Hinojosa J, Castro L, Jurado C, Gómez-Beldal AB. Bermejo F, et al. Rev Esp Enferm Dig. 2004 Feb;96(2):94-101. doi: 10.4321/s1130-01082004000200002. Rev Esp Enferm Dig. 2004. PMID: 15255018 Free article. English, Spanish.

4

Mercaptopurine and inflammatory bowel disease: the other thiopurine.

Bermejo San José F, Algaba A, López Durán S, Guerra I, Aicart M, Hernández-Tejero M, Garrido E, de Lucas M, Bonillo D, López Sanromán A. Bermejo San José F, et al. Rev Esp Enferm Dig. 2017 Jan;109(1):10-16. doi: 10.17235/reed.2016.4546/2016. Rev Esp Enferm Dig. 2017. PMID: 27809554 Free article.

5

[Efficacy of premedication with intravenous corticosteroids and antihistaminics in preventing infusion reactions to infliximab].

Bermejo F, López San Román A, Algaba A, van Domselaar M, Carneros JA, Rivero M, Piqueras B, Valer MP. Bermejo F, et al. Gastroenterol Hepatol. 2008 Dec;31(10):629-32. doi: 10.1016/S0210-5705(08)75809-6. Epub 2009 Jan 7. Gastroenterol Hepatol. 2008. PMID: 19174078 Spanish.

6

Healing of Helicobacter pylori gastric ulcers: only eradication matters.

Bermejo F, Boixeda D, Martín De Argila C, López San Román A, Defarges V, Hernández Ranz H, Vázquez M, García Plaza A. Bermejo F, et al. Rev Esp Enferm Dig. 2003 Sep;95(9):625-8, 621-4. Rev Esp Enferm Dig. 2003. PMID: 14738407 English, Spanish.

7

Adherence to treatment in inflammatory bowel disease.

López San Román A, Bermejo F, Carrera E, Pérez-Abad M, Boixeda D. López San Román A, et al. Rev Esp Enferm Dig. 2005 Apr;97(4):249-57. doi: 10.4321/s1130-01082005000400005. Rev Esp Enferm Dig. 2005. PMID: 15982180 Free article. English, Spanish.

8

Mercaptopurine rescue after azathioprine-induced liver injury in inflammatory bowel disease.

Bermejo F, López-Sanromán A, Algaba A, Van-Domselaar M, Gisbert JP, García-Garzón S, Garrido E, Piqueras B, De La Poza G, Guerra I. Bermejo F, et al. Aliment Pharmacol Ther. 2010 Jan;31(1):120-4. doi: 10.1111/j.1365-2036.2009.04132.x. Aliment Pharmacol Ther. 2010. PMID: 19709096 Free article.

9

Factors that modify therapy adherence in patients with inflammatory bowel disease.

Bermejo F, López-San Román A, Algaba A, Guerra I, Valer P, García-Garzón S, Piqueras B, Villa C, Bermejo A, Rodríguez-Agulló JL. Bermejo F, et al. J Crohns Colitis. 2010 Oct;4(4):422-6. doi: 10.1016/j.crohns.2010.01.005. Epub 2010 Feb 12. J Crohns Colitis. 2010. PMID: 21122538

10

Pharmacological Approach to the Management of Crohn's Disease Patients with Perianal Disease.

Bermejo F, Guerra I, Algaba A, López-Sanromán A. Bermejo F, et al. Drugs. 2018 Jan;78(1):1-18. doi: 10.1007/s40265-017-0842-x. Drugs. 2018. PMID: 29139091 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

196 results

Search Page

Filters